Use of volatile compositions to limit or eliminate the perception of malodor

US2020345601A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020345601-A1
Application numberUS-201816760031-A
CountryUS
Kind codeA1
Filing dateNov 21, 2018
Priority dateNov 22, 2017
Publication dateNov 5, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The various aspects presented herein relate to the perfumery industry. More particularly, the various aspects presented herein relate to the use of volatile compositions to limit, decrease or eliminate the perception of malodor. Such compositions include at least one malodor antagonist optionally combined with perfuming ingredients. Such compositions, their use in combination with delivery systems and their applications in consumer products are also objects of the present disclosure.

First claim

Opening claim text (preview).

1 . A method to inhibit, reduce, or suppress the perception of a malodor in a subject, comprising contacting the subject with at least one compound selected from the group consisting of: (1RS,6RS,11RS)-2,2,9,11-tetramethylspiro[5.5]undec-8-en-1-yl acetate, (+−)-2,2,7,11-tetramethylspiro[5.5]undec-8-en-1-yl-acetate, (+−)-2,3,7,7-tetramethylspiro[4.5]dec-2-en-6-yl acetate, (+−)-2,3,7,7-tetramethylspiro[4.5]dec-6-yl acetate, 1,5,10,10-tetramethylspiro[5.5]undec-3-en-11-yl acetate, 2,3,9,9-tetramethylspiro[4.5]decan-10-yl) acetate, (5,10,10-trimethylspiro[5.5]undec-2-en-11-yl) formate, (3,5,10,10-tetramethylspiro[5.5]undec-2-en-11-yl) acetate, (2,3,9,9-tetramethylspiro[4.5]dec-2-en-10-yl) acetate, (9,9-dimethylspiro[4.5]dec-2-en-10-yl) acetate, 10-methoxy-9,9-dimethylspiro[4.5]dec-2-ene, 4,10,10,11-tetramethylspiro[5.5]undec-2-en-11-ol, 5,10,10,11-tetramethylspiro[5.5]undec-3-en-11-ol, a mixture of 4,10,10,11-tetramethylspiro[5.5]undec-2-en-1-ol and 5,10,10,11-tetramethylspiro[5.5]undec-3-en-11-ol, 2,4,8-trimethylspiro[5.5]undec-3-en-11-ol, 2,9,11-trimethylspiro[5.5]undec-9-en-5-ol, a mixture of 2,4,8-trimethylspiro[5.5]undec-3-en-11-ol and 2,9,11-trimethylspiro[5.5]undec-9-en-5-ol, 3-methyl-5-propan-2-ylspiro[5.5]undec-2-en-11-ol, 11-methylspiro[5.5]undecan-5-ol, 3,10,10-trimethylspiro[5.5]undec-3-en-11-ol, 4,10,10-trimethylspiro[5.5]undec-3-en-11-ol, a mixture of 3,10,10-trimethylspiro[5.5]undec-3-en-11-ol and 4,10,10-trimethylspiro[5.5]undec-3-en-11-ol [2,2-dimethyl-1-(2,4,6-trimethylcyclohex-3-en-1-yl)propyl] acetate, [2,2-dimethyl-1-(2,4,6-trimethylcyclohexyl)propyl] acetate, (1RS)-2,2-dimethyl-1-[(1SR,2SR)-2-methylcyclohexyl]propyl acetate, 9,9-dimethylspiro[4.5]dec-2-en-10-ol, 2,3,9,9-tetramethylspiro[4.5]decan-10-ol, (2,2,3,3,9,9-hexamethylspiro[4.5]decan-10-yl) acetate, 9-methoxy-8,8-dimethylspiro[4.4]non-2-ene, (8,8-dimethylspiro[4.4]non-2-en-9-yl) acetate, 2,3,8,8-tetramethylspiro[4.4]non-2-en-9-one, 2,3,9,9-tetramethylspiro[4.5]dec-2-en-10-ol, 4-methoxy-3,3-dimethylspiro[4.4]nonane, (4,9,9-trimethylspiro[4.5]dec-2-en-10-yl) acetate, 2,4,9,9-tetramethylspiro[4.5]dec-2-en-10-ol, (2,3,9,9-tetramethylspiro[4.5]dec-2-en-10-yl) formate, (2,4,9,9-tetramethylspiro[4.5]dec-2-en-10-yl) acetate, (+−)-2,3-dimethylspiro[4.5]dec-2-en-6-yl acetate, (4 ˜ {S},5 ˜ {R},6 ˜ {S},11 ˜ {S})-4,11-dimethylspiro[5.5]undecan-5-ol, 9,9-dimethylspiro[4.5]dec-2-en-10-one, 2,3,9,9-tetramethylspiro[4.5]dec-2-en-10-one, 2,4,9,9-tetramethylspiro[4.5]dec-2-en-10-one, 1,1′,1′,5-tetramethyl-2′-methylidenespiro[6-oxabicyclo[3.1.0]hexane-3,3′-cyclohexane], 4,9,9-trimethylspiro[4.5]dec-2-en-10-one, 2,2-dimethyl-6,6-bis(2-methylprop-2-enyl)cyclohexan-1-one, 2,2-dimethyl-5,5-bis(2-methylprop-2-enyl)cyclopentan-1-one, 2-but-3-en-2-yl-6,6-dimethyl-2-prop-2-enylcyclohexan-1-one, 2,2-bis(2-methyl-2-propen-1-yl)cyclohexanone, a mixture of 2-but-3-en-2-yl-6,6-dimethyl-2-prop-2-enylcyclohexan-1-one and 2,2-bis(2-methyl-2-propen-1-yl)cyclohexanone, 2,2-dimethyl-1-(2-methylcyclohexyl)propan-1-ol, 2,2-dimethyl-1-(3-methylcyclohexyl)propan-1-ol, a mixture of 2,2-dimethyl-1-(2-methylcyclohexyl)propan-1-ol and 2,2-dimethyl-1-(3-methylcyclohexyl)propan-1-ol, 2,2-dimethyl-6,6-bis(2-methylprop-2-enyl)cyclohexan-1-ol, 1-methoxy-2,6-dimethyl-1-prop-2-enylcyclohexane, methyl 1-(3-methylbut-2-enyl)cyclohex-2-ene-1-carboxylate, methyl 1-(3-methylbut-2-enyl)cyclohex-3-ene-1-carboxylate, a mixture of methyl 1-(3-methylbut-2-enyl)cyclohex-2-ene-1-carboxylate and methyl 1-(3-methylbut-2-enyl)cyclohex-3-ene-1-carboxylate, 2,2-dimethyl-5,5-bis(2-methylprop-2-enyl)cyclopentan-1-ol, 1-(2,6-dimethylcyclohex-3-en-1-yl)-2,2-dimethylpropan-1-ol, 1-(2-methyl-4-tricyclo[5.2.1.01,5]decanyl)ethyl acetate, 1-(2,4-dimethyl-4-tricyclo[5.2.1.0{circumflex over ( )}1,5]decanyl)ethyl acetate, 1-((1R,3S,3aS,6S)-1,2,3-trimethyloctahydro-3a,6-methanoinden-1-yl)ethan-1-one, 1-(2,4-dimethyl-4-tricyclo[5.2.1.0{circumflex over ( )}{1,5}]decanyl)ethanone, 2,3,4-trimethyltricyclo[5.2.1.0{circumflex over ( )}{1,5}]decane-4-carbaldehyde, (2,3,4-trimethyl-4-tricyclo[5.2.1.0{circumflex over ( )}{1,5}]decanyl)methyl acetate, 1-((3aS,6S)-2,3-dimethyloctahydro-3a,6-methanoinden-1-yl)ethan-1-one oxime, 1,3-dimethyloctahydro-3a,6-methanoindene-1-carbaldehyde oxime, ˜ {N}-[1-[(1 ˜ {R},7 ˜ {R})-2,3,4-trimethyl-4-tricyclo[5.2.1.01,5]decanyl]ethylidene]hydroxylamine, (+−)-1-(2,4-dimethyltricyclo[5.2.1.01.5]dec-4-yl) ethanone, (+−)-1-(2,4-dimethyltricyclo[5.2.1.0 ˜ 1.5 ˜ ]dec-4-yl) ethyl acetate, 1-[(1RS,2RS,4SR,7RS)-2,3,4-trimethyltricyclo[5.2.1.01. ˜ ]dec-4-yl) ethanone, (E/Z)-1-[(1RS,7RS)-2,3-dimethyltricyclo[5.2.1.01.5]dec-4-yl) ethanone oxime, (E/Z)-1-[(1S,7S)-2,3,4-trimethyltricyclo[5.2.1.0 ˜ 1.5 ˜ ]dec-4-yl) ethanone oxime, (E/Z)-1-((3aS,6S)-1,2,3-trimethyloctahydro-3a,6-methanoinden-1-yl)ethanone oxime, (+−)-1-(3-methyloctahydro-3a,6-methanoinden-1-yl)ethyl acetate, [1R-(1R*,4R*,6R*,10S*)]-4,12,12-trimethyl-9-methylene-5-oxatricyclo[8.2.0.04,6]dodecane, 1-2,6,6-trimethyl-3-cyclohexen-1-yl-2-buten-1-one, 2-tertbutyl phenol, 5-Methyl-2-(propan-2-yl)phenol, nona-2,6-dienal, 1,1-diethoxy-3,7-dimethylocta-2,6-diene, 3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde, 1,4,8-trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene; 1,5,8-trimethyl-13-oxabicyclo[10.1.0]trideca-4,8-diene, 3-(4-tert-butylphenyl)propanal, (4R,4aS,6R)-4,4a-dimethyl-6-prop-1-en-2-yl-3,4,5,6,7,8-hexahydronaphthalen-2-one, geranyl acetate, 1-(3,3-dimethylcyclohexen-1-yl)pent-4-en-1-one; 1-(5,5-dimethylcyclohexen-1-yl)pent-4-en-1-one, 1-(3,3-dimethylcyclohexen-1-yl)pent-4-en-1-one; 1-(5,5-dimethylcyclohexen-1-yl)pent-4-en-1-one, 2-ethoxy-5-prop-1-enylphenol, 2,6,6,8-tetramethyl-9-oxatetracyclo[5.4.1.0{circumflex over ( )}{1,5}0{circumflex over ( )}{8,10}]dodecane, nonylenic aldehyde, isobutylquinoline, cyclopentadec-4-en-1-one, (−)-(R)-3,7-dimethyl-6-octenenitrile, 2-methyl-5-propan-2-ylphenol, isopropyl quinolone, 5-hexyl-2-methylpyridine, (2,5-dimethyl-1,3-dihydroinden-2-yl)methanol, 2-pentylcyclopentan-1-one, 4-(2,6,6-trimethylcyclohexen-1-yl)but-3-en-2-one; 4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one, 3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; 1-(2,6,6-trimethylcyclohex-2-en-1-yl)pent-1-en-3-one, 2,4-dimethylcyclohex-3-enecarbaldehyde, phenylethylol, 3,7-dimethylocta-2,6-dienal, (2,2,2-trichloro-1-phenylethyl) acetate, 4-(2,6,6-trimethylcyclohexen-1-yl)but-3-en-2-one, phenyl ethyl acetate, 7-hydroxy-3,7-dimethyloctanal, methyl citral, 6,10-dimethylundeca-5,9-dien-2-one, 2-ethoxy-5-prop-1-enylphenol, (4-methyl-4-phenylpentan-2-yl) acetate, (+−)-3-methylcyclopentadecanone, 1-(4,8-dimethyl-12-methylidenecyclododeca-4,8-dien-1-yl)ethanone; 1-(2,6,10-trimethylcyclododeca-1,5,9-trien-1-yl)ethanone; 1-(2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl)ethanone, cyclododecanone, (Z)-3,4,5,6,6-pentamethylhept-3-en-2-one, 1,4-dioxacyclohexadecane-5,16-dione, pentanol, oxacyclohexadecan-2-one, 1,1,2,3,3-pentamethyl-2,5,6,7-tetrahydroinden-4-one, (+−)-perhydro-5,5,8A-trimethyl-2-trans-naphthalenone, 2,3,3-trimethyl-2H-inden-1-one, 4-(4,8-dimethylnona-3,7-dienyl)pyridine, 4-[(1 ˜ {R},3 ˜ {R},6 ˜ {R})-2,2,3,6-tetramethylcyclohexyl]but-3-en-2-one; 4-[( 1 ˜ {S},3 ˜ {S},6 ˜ {R})-2,2,3,6-tetramethylcyclohexyl]but-3-en-2-one, (+)-(1R,7R)-10,10-dimethyl-tricyclo[7.1.1.0(2,7)]undec-2-en-4-one, (9<1>E</I>)-cycloheptadec-9-en-1-one, 8,8-dimethyl-2,3,4,6,7,8 ˜ {a}-hexahydro-1 ˜ {H}-naphthalene-2-carbaldehyde; 8,8-dimethyl-2,3,5,6,7,8 ˜ {a}-hexahydro-1 ˜ {H}-naphthalene-2-carbaldehyde; 8,8-dimethyl-2,3,4,5,6,7-hexahydro-1 ˜ {H}-naphthalene-2-carbaldehyde; 2,2-dimethyl-octahydro-1 ˜ {H}-2,4 ˜ {a}-methan, 2,4 ˜ {a},8,8-tetramethyl-1 ˜ {a},2,4,5,6,7-hexahydro-{H}-cyclopropa[j]naphthalen-3-one; 2,6,6,8-tetramethyltricyclo[5.3.1.01,5]undecan-9-one, (+−)-(3E)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one, (+−)-3,6,8,8-tetramethyloctahydro-1H-3a,7-methanoazulen-6-ol, (1RS,2SR,5RS,7RS,8SR)-5-methyltricyclo[6.2.1.

Assignees

Inventors

Classifications

  • Ketones, e.g. benzophenone · CPC title

  • the ring containing six carbon atoms · CPC title

  • Ingredients · CPC title

  • compounds containing condensed hydrocarbon rings · CPC title

  • Deodorant compositions {(compositions released by contact with a liquid A61L9/05)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020345601A1 cover?
The various aspects presented herein relate to the perfumery industry. More particularly, the various aspects presented herein relate to the use of volatile compositions to limit, decrease or eliminate the perception of malodor. Such compositions include at least one malodor antagonist optionally combined with perfuming ingredients. Such compositions, their use in combination with delivery syst…
Who is the assignee on this patent?
Firmenich & Cie
What technology area does this patent fall under?
Primary CPC classification A61K8/33. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).